2m 2m 2m 2m 2m 2m 2m
ERNEXA THERAPE (ERNA)
NASDAQ
$5.74+$0.20 (+3.52%)
Price as of Jul 14, 2026 7:38 AM EDT- $6.5MMarket Cap
- -88.69%1-Year Change
- BiotechnologyIndustry
ERNEXA THERAPE (ERNA)
$5.74+$0.20 (+3.52%)
ERNA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $5.54 | ||
Change | -$0.52 (-8.58%) | ||
Open | $5.86 | ||
High | $6.00 | ||
Low | $5.50 | ||
Previous Close | $6.06 | ||
Volume | 20,564 | ||
30-Day Average Volume | 51,326 | ||
1-Week Change | -13.98% | ||
1-Month Change | -9.92% | ||
1-Year Change | -88.69% | ||
3-Year Change | -99.43% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 1.2M | ||
Total Assets | $10.5M | ||
Market Cap | $6.5M | ||
Enterprise Value | -$1.0M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | -$2.3M | ||
EBIT | -$40,000.00 | ||
EBITDA | -$32,000.00 | ||
Net Working Capital | $6.5M | ||
EPS | -$173.75 | ||
Enterprise Value/EBITDA | 32 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -0 | ||
PEG | N/A | ||
Price/Free Cash Flow | -3 | ||
Price/Operating Cash Flow | -3 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 25 | ||
Last Split Date | 05/04/2026 | ||
Earnings & Revenue